BIOSOUND PHASE 2 DIAGNOSTIC ULTRASOUND SYSTEM— 510(k) K895645

Name: FDA 510(k) clearance K895645
Creator: U.S. Food and Drug Administration
Published: 1990-03-06

Substantially Equivalent

Biosound, Inc.

FDA 510(k) clearance K895645 for BIOSOUND PHASE 2 DIAGNOSTIC ULTRASOUND SYSTEM, Substantially Equivalent on 1990-03-06. Applicant: Biosound, Inc.. Device class: 2.

Clearance details

Applicant: Biosound, Inc.
Product code: Code IYO
Device class: Class 2
Regulation: 21 CFR 892.1560
Advisory panel: Radiology
Date received: 1989-09-20
Decision date: 1990-03-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code IYO

view all

K253452 — Accuro 3S2026-07-24
K260190 — ARTHUR2026-06-18
K252237 — EdgeFlow UW202026-04-17
K254021 — Accuro XV2026-04-09
K253898 — QT Scanner 2000 Model A2026-03-04

More clearances from Biosound, Inc.

view all

K971700 — BIOPSY ACCESSORY FOR ULTRASOUND TRANSDUCER1997-07-09
K963936 — ACCESSPOINT, MED E-MAIL, DICOM READER1997-03-31
K963262 — ARTOSCAN M1997-03-28
K963662 — GALILEO EVOKED POTENTIALRE1997-02-26
K953716 — INTRACAVITY TRANSDUCERS1996-04-17

Adverse events under product code IYO

product code IYO

Malfunction: 3,339
Total: 3,339

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.